Greeting
COMPANY VISION
We are a pioneering biotechnology and pharmaceutical entity committed to advancing
human health through the application of the Sturgeon's exceptional regenerative properties.
Our primary corporate objective is the development and validation of RSO
(Refined Sturgeon Oil) as an API, a novel substance derived from sturgeon.
Our vision is to introduce sturgeon based new drugs globally for the treatment of chronic
wounds, pressure ulcers and other skin diseases. This initiative is aimed at significantly
accelerating patient recovery, mitigating associated suffering, and fundamentally elevating
the quality of life for those afflicted.
Our enterprise is resolutely dedicated to translating the powerful biogenic potential of the sturgeon
into effective pharmaceutical substances. We aspire to become a global leader in sturgeon
regenerative biotech, consistently delivering verifiable healing and renewed hope to the patients.
Global Trust, Bio-Innovation Excellence.
GMP Manufacturing Facility Construction Plan
STURGEONUSA has acquired a GMP certified space at the West Virginia Innovation Corporation
facility through a partnership with BlueBio.
This strategic facility development is planned in two distinct phases:
Phase 1: RSO(Refined Sturgeon Oil) Production
The initial phase focuses on the complete acquisition and validation of
GMP-certified equipment for the production of RSO.Phase 2: Preparation will immediately commence for the expansion of the GMP-certified
facility. This expansion is dedicated to the manufacturing of pharmaceutical products,
beginning with the production of Total Care Cream as a compound designated
for a NDA(New Drug Application) filing.
Upon completion of the Phase 1, we will immediately initiate the preparation
for Phase 2 to secure our global production capacity.
